Ir a las Transacciones
Consumo & Retail | Salud

Innoxa has sold its eye care activity to Biosynex Group

The private shareholders of Laboratoires Innoxa have sold the company’s eye care activity to Biosynex Group.

Founded in 1920 in Paris by Dr. François Debat, a French pharmacist, Laboratoires Innoxa is a premium brand recognized worldwide for its expertise in the field of ophthalmology and optics. In 2020, the company was acquired by Frédéric and Laetitia Poux, who conducted a complete refoundation of the portfolio. The brand launched its first products in September 2021 and a new patented best-seller – the blue eye drops – in June 2022. Innoxa’s eye care activity now includes seven references with patented formulas, which comply with the latest European health and safety standards. The company’s product portfolio is structured around four areas: eye drops, eye sprays, contactology and optical sprays. The brand distributes its products in several countries, mostly in Europe and Asia, with core markets in France and China. Innoxa has a multichannel strategy with a historical presence in pharmacies and a focus on online platforms such as Amazon.fr and e-parapharmacies.

Founded in 2005, Biosynex is a leading public health player in France and Europe. The group offers innovative healthcare solutions to a wide range of users through two divisions: Biosynex Pharma (specialized in self-diagnostics and family health products) and Biosybex Diagnostic (developing and offering in vitro diagnostic medical devices). The group employs over 500 people, has a presence in 95 countries, and generated approximately US$212 in sales in 2022.

Oaklins’ team in France acted as M&A advisor to Laboratoires Innoxa in this transaction.

Partes

Contáctese con el equipo de la transacción

Ludovic Beaulieu

Socio
Paris, Francia
Oaklins France

Charlotte Delphis

Asociado Director
Paris, Francia
Oaklins France

Transacciones relacionadas

Pharma-Skan & Skan-Medic have been acquired by Brygge Partners
Salud

Pharma-Skan & Skan-Medic have been acquired by Brygge Partners

Pharma-Skan, an independent contract manufacturing organization (CMO), and Skan-Medic, a manufacturer of over-the-counter (OTC) products, both operating as a joint entity, have been acquired by Brygge Partners.

Conozca más
Ambala Foods Limited has been acquired by Cake Box Holdings plc
Consumo & Retail | Alimentos

Ambala Foods Limited has been acquired by Cake Box Holdings plc

Cake Box Holdings plc has acquired the Asian dessert specialist Ambala Foods Limited.

Conozca más
BDS Vending Solutions has been acquired by Coca-Cola HBC Northern Ireland, a subsidiary of Coca-Cola HBC
Consumo & Retail | Alimentos

BDS Vending Solutions has been acquired by Coca-Cola HBC Northern Ireland, a subsidiary of Coca-Cola HBC

Coca-Cola HBC Northern Ireland, a subsidiary of Coca-Cola HBC, has completed the acquisition of BDS Vending Solutions. This transaction is aligned with Coca-Cola HBC’s strategy to strengthen its route-to-market and direct-to-consumer capabilities, opening up new opportunities across its diverse portfolio of snacks, as well as cold and hot beverages.

Conozca más